腰痹通胶囊联合椎间孔镜治疗腰椎间盘突出症疗效观察及对VAS、JOA 评分的影响
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R681.53

基金项目:


Curative Effect of Yaobitong Capsules Combined with Endoscopic Lumbar Discectomy on Lumbar Disc Herniation and Its Effect on Scores of VAS and JOA
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察腰痹通胶囊联合椎间孔镜治疗腰椎间盘突出症的疗效及对视觉模拟评分法(VAS)、日 本骨科协会(JOA) 评分的影响。方法:选取102 例腰椎间盘突出症患者作为研究对象,按随机数字表法分为 对照组及观察组各51 例。2 组均行经皮椎间孔镜下髓核摘除术,观察组在此基础上加用腰痹通胶囊。观察 2 组临床疗效及不良反应发生率,比较2 组治疗前后中医证候评分的变化,比较2 组治疗前后VAS、JOA 评分 的变化。结果:治疗后,2 组腰腿痛如刺、痛有定处、腰部板硬、日轻夜重、舌暗紫或有瘀斑中医证候评分均 较治疗前下降(P<0.05),观察组上述5 项中医证候评分均低于对照组(P<0.05)。对照组临床疗效总有效率 为80.39%,观察组总有效率为92.15%,2 组比较,差异有统计学意义(P<0.05)。治疗后1 个月、3 个 月、6 个月,2 组VAS 评分均较治疗前下降(P<0.05);治疗后1 个月、3 个月、6 个月观察组VAS 评分均低 于对照组(P<0.05)。治疗后1 个月、3 个月、6 个月,2 组JOA 评分均较治疗前升高(P<0.05),观察组治 疗后1 个月、3 个月、6 个月JOA 评分均高于对照组(P<0.05)。对照组不良反应发生率为11.76%,观察组不 良反应发生率为3.92%,2 组比较,差异有统计学意义(P<0.05)。结论:腰痹通胶囊联合椎间孔镜治疗腰椎 间盘突出症能提高疗效,减轻疼痛,改善腰椎功能,降低不良反应发生率。

    Abstract:

    Objective: To observe the curative effect of the therapy of Yaobitong Capsules combined with endoscopic lumbar discectomy on lumbar disc herniation and its effect on the scores of Visual Analogue Scale (VAS) and Japanese Orthopaedic Association (JOA). Methods:A total of 102 patients with lumbar disc herniation were selected as the study objects, and divided into the control group and the observation group according to the random number table method, with 51 cases in each group. Both groups were given endoscopic lumbar discectomy,based on which the observation group was additionally treated with Yaobitong Capsules. The clinical effects and incidence of adverse reactions in both groups were observed;the changes of traditional Chinese medicine (TCM) syndrome scores before and after treatment and scores of VAS and JOA before and after treatment were compared between the two groups. Results: After treatment, the TCM syndrome scores of stabbing pain in the waist and lower extremities, fixed pain,board-like consistency of the waist,daily alleviating and night worsening pain,dark purple tongue or tongue with ecchymosis in both groups were decreased when compared with those before treatment (P< 0.05),and the above five scores in the observation group were lower than those in the control group (P< 0.05). The total clinical effective rate was 80.39% in the control group and 92.15% in the observation group, the difference being significant (P<0.05). One month,three months and six months after treatment,the VAS scores in both groups were decreased when compared with those before treatment (P<0.05), and the VAS scores in the observation group one month,three months and six months after treatment were respectively lower than those in the control group (P<0.05). One month, three months and six months after treatment, the JOA scores in both groups were increased when compared with those before treatment (P<0.05), and the JOA scores in the observation group at one month, three months and six months after treatment were respectively higher than those in the control group (P<0.05). The incidence of adverse reactions was 11.76% in the control group and 3.92% in the observation group, the difference being significant (P<0.05). Conclusion: The therapy of Yaobitong Capsules combined with endoscopic lumbar discectomy can enhance the curative effect on lumbar disc herniation,mitigate the pain,improve the lumbar vertebral function and decrease the incidence of adverse reactions.

    参考文献
    相似文献
    引证文献
引用本文

丁志清,喻灿明,颜峰.腰痹通胶囊联合椎间孔镜治疗腰椎间盘突出症疗效观察及对VAS、JOA 评分的影响[J].新中医,2023,55(23):120-124

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-12-13
  • 出版日期:
文章二维码